Inolex is making further investments in its leadership team with the recent appointment of Michael Dall as Chief Financial Officer and Ron Lopez as Vice President Operations.
The announcement comes after the company shared news earlier this month on its expanded Board of Directors with the addition of nationally recognised attorney, Suzanne S. Mayes.
In this new role, Dall will provide pivotal leadership to the company’s overall financial strategy and its strong position for global development. Dall, who served in executive roles at channel disrupting brands Wawa, Walgreens, Aramark, and BrightView, has guided Inolex with a steady hand through its growth and development over the past five years. He will take on broader responsibility for managing the financial health of the company as it delivers its portfolio of sustainable ingredients to new and extended markets.
“Mike has extensive financial and operational expertise across retail, healthcare, and consumer industries, but his north star is the invaluable, entrepreneurial spirit he exudes having worked early on in a private family business,” notes David Plimpton, CEO of Inolex. Inolex also announced the promotion of Ron Lopez to VP Operations. Lopez has been at the helm of the company’s flagship manufacturing facility in Charlotte, USA since 2021. He has led the team responsible for ensuring continuous production and global fulfilment of Inolex ingredients to customers despite recent supply chain and global challenges.
“We are ingredient designers, and sustainability is central to who we are and all that we do. Ron has a talent for seeing the big picture, putting the Principles of Green Chemistry, smart engineering, and data-informed practices to work to realise our vision for sustainable ingredients on a worldwide scale,” said Plimpton.
